Concepedia

Larry Tsai

LT

26

Publications

2.7K

Citations

18

H-Index

1996

Active since

Affiliations

Baylor College of Medicine(Current)

Roche (United Kingdom)

Tetraphase Pharmaceuticals (United States)

Roche (Switzerland)

Brigham and Women's Hospital

Larry Tsai is an author at Baylor College of Medicine specializing in medicine, health sciences, and cell biology.

ORCID

Top concepts

Publications per year

1996–2023

26

Publications

26

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

Joseph S. Solomkin, David C. Evans, Algirdas Šlepavičius et al. · JAMA Surgery · 2016 · 250 citations

IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections

Joseph S. Solomkin, Jānis Gardovskis, Kenneth Lawrence et al. · Clinical Infectious Diseases · 2018 · 187 citations · Full text

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · 2020 · 132 citations · Full text

, , +9

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Iván O. Rosas, George Diaz, Robert Gottlieb et al. · Intensive Care Medicine · 2021 · 124 citations · Full text

Rows per page

1–5 of 26